April 24, 2015CDP Extends Accenture Contract for Digital Strategy and Technology Services That Help Improve Environmental Performance of Companies and Cities
LONDON; Apr. 24, 2015 – CDP, formerly the Carbon Disclosure Project, has appointed Accenture as its Global Digital Partner in an agreement that extends the two organizations’ relationship which began in 2010. The new contract extends Accenture’s support for a further 12 months.
April 24, 2015Accenture Ranks 15th on DiversityInc Top 50 Companies for Diversity®
NEW YORK; April 24, 2014 – Accenture has been named a 2015 DiversityInc Top 50 Company for Diversity for the ninth year, marking the company’s fourth consecutive year in the Top 15.
April 23, 2015Majority of U.S Citizens Feel Safe in Their Neighborhoods but Want Police to Increase Community Collaboration and Their Use of Digital Communication Tools
CAMBRIDGE, Mass.; April 23, 2015 – While the vast majority of U.S. citizens feel safe in their neighborhoods, more than three-fourths (76 percent) believe there is room for improvement in how police services are delivered locally, according to results of an Accenture (NYSE: ACN) survey of 2,000 U.S. citizens.
April 23, 2015Accenture Duck Creek Templates Updated to Help Insurers More Easily Develop Products with New ISO Cyber Liability Coverage Options
NEW YORK; April 23, 2015 – Accenture (NYSE: ACN) announced new cyber liability coverage options from ISO, a Verisk Analytics company, are now available through Accenture Duck Creek Templates. The newly integrated cyber liability endorsements will allow insurers to more easily create and sell cyber security coverage to customers.
April 22, 2015Accenture and Oracle Enhance the Accenture Life Sciences Cloud for R&D with the Introduction of an End-to-End Clinical Data Management Capability
NEW YORK; Apr. 22, 2015 – Accenture (NYSE: ACN) has expanded the Accenture Life Sciences Cloud for Research and Development (R&D) powered by Oracle with the addition of enhanced clinical data management capabilities. This enables life sciences companies to generate high-quality, reliable and statistically sound data from clinical trials to reduce the time, effort and cost needed to take drugs from development to market.